Puma Bio (PBYI) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Puma Bio Revenue Highlights

Latest Revenue (Y)

$228.37M

Latest Revenue (Q)

$54.48M

Main Segment (Y)

Product

Main Geography (Y)

Royalty

Puma Bio Revenue by Period

Puma Bio Revenue by Year

Date	Revenue	Change
2025-12-31	$228.37M	-0.91%
2024-12-31	$230.47M	-2.19%
2023-12-31	$235.64M	3.34%
2022-12-31	$228.03M	-9.92%
2021-12-31	$253.16M	12.46%
2020-12-31	$225.11M	-17.32%
2019-12-31	$272.26M	8.47%
2018-12-31	$251.00M	806.14%
2017-12-31	$27.70M	100.00%
2016-12-31	-	100.00%
2015-12-31	-	100.00%
2014-12-31	-	100.00%
2013-12-31	-	100.00%
2012-12-31	-	-100.00%
2011-12-31	$-281.10K	100.00%
2010-12-31	-	100.00%
2009-12-31	-	100.00%
2008-12-31	-	100.00%
2007-12-31	-	-

Puma Bio generated $228.37M in revenue during NA 2025, up -0.91% compared to the previous quarter, and up 101.45% compared to the same period a year ago.

Puma Bio Revenue by Quarter

Date	Revenue	Change
2025-09-30	$54.48M	3.89%
2025-06-30	$52.44M	13.97%
2025-03-31	$46.01M	-22.12%
2024-12-31	$59.08M	-26.65%
2024-09-30	$80.54M	71.06%
2024-06-30	$47.08M	7.58%
2024-03-31	$43.77M	-39.36%
2023-12-31	$72.18M	28.62%
2023-09-30	$56.12M	2.84%
2023-06-30	$54.57M	3.40%
2023-03-31	$52.77M	-19.64%
2022-12-31	$65.67M	15.01%
2022-09-30	$57.10M	-4.06%
2022-06-30	$59.52M	30.13%
2022-03-31	$45.74M	-17.38%
2021-12-31	$55.36M	19.70%
2021-09-30	$46.24M	-13.37%
2021-06-30	$53.38M	-45.62%
2021-03-31	$98.17M	86.63%
2020-12-31	$52.60M	3.64%
2020-09-30	$50.75M	-28.09%
2020-06-30	$70.58M	37.81%
2020-03-31	$51.22M	-18.60%
2019-12-31	$62.92M	11.56%
2019-09-30	$56.40M	4.60%
2019-06-30	$53.92M	-45.59%
2019-03-31	$99.10M	39.38%
2018-12-31	$71.10M	13.58%
2018-09-30	$62.60M	23.31%
2018-06-30	$50.77M	-23.68%
2018-03-31	$66.52M	207.94%
2017-12-31	$21.60M	255.44%
2017-09-30	$6.08M	100.00%
2017-06-30	-	100.00%
2017-03-31	-	100.00%
2016-12-31	-	100.00%
2016-09-30	-	100.00%
2016-06-30	-	100.00%
2016-03-31	-	100.00%
2015-12-31	-	100.00%
2015-09-30	-	100.00%
2015-06-30	-	100.00%
2015-03-31	-	100.00%
2014-12-31	-	100.00%
2014-09-30	-	100.00%
2014-06-30	-	100.00%
2014-03-31	-	100.00%
2013-12-31	-	100.00%
2013-09-30	-	100.00%
2013-06-30	-	100.00%
2013-03-31	-	100.00%
2012-12-31	-	100.00%
2012-09-30	-	100.00%
2012-06-30	-	100.00%
2012-03-31	-	100.00%
2011-12-31	-	100.00%
2011-09-30	-	100.00%
2011-06-30	-	100.00%
2011-03-31	-	100.00%
2010-12-31	-	100.00%
2010-09-30	-	100.00%
2010-06-30	-	100.00%
2010-03-31	-	100.00%
2009-12-31	-	100.00%
2009-09-30	-	100.00%
2009-06-30	-	100.00%
2009-03-31	-	100.00%
2008-12-31	-	100.00%
2008-09-30	-	100.00%
2008-06-30	-	100.00%
2008-03-31	-	100.00%
2007-12-31	-	-

Puma Bio generated $54.48M in revenue during Q3 2025, up 3.89% compared to the previous quarter, and up 115.70% compared to the same period a year ago.

Puma Bio Revenue Breakdown

Puma Bio Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 20	Dec 19	Dec 18
Royalty	$24.30M	$35.28M	$5.68M	$391.00K	-
Product	$204.07M	$195.19M	$211.62M	$200.49M	-
License	-	-	$2.50M	$60.25M	$50.50M

Puma Bio's latest annual revenue breakdown by segment (product or service), as of Dec 25: Product (89.36%), and Royalty (10.64%).

Quarterly Revenue by Product

Product/Service	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Dec 18	Sep 18	Jun 18
Royalty	$15.57M	$2.57M	$3.25M	$2.90M	$8.19M	$24.41M	$2.69M	$4.28M	$2.35M	$2.54M	$1.42M	$1.11M	$608.00K	$216.00K	$120.00K	$55.00K	-	-	-	-
Product	$59.88M	$51.90M	$49.19M	$43.10M	$94.66M	$56.14M	$44.40M	$48.86M	$50.02M	$48.77M	$48.61M	$58.71M	$53.48M	$53.86M	$45.57M	$61.08M	$52.63M	$50.77M	-	-
License	-	-	-	-	-	-	-	$250.00K	$2.50M	$2.70M	$20.70M	$2.00M	$4.00M	$2.75M	-	$53.50M	$10.00M	$10.00M	$30.50M	-

Puma Bio's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Product (79.36%), and Royalty (20.64%).

Puma Bio Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 20	Dec 19	Dec 18
Royalty	$5.68M	$391.00K	-
License	$2.50M	$60.25M	$50.50M
Product	-	$211.62M	$200.49M

Puma Bio's latest annual revenue breakdown by geography, as of Dec 20: Royalty (69.45%), and License (30.55%).

Quarterly Revenue by Country

Country	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19	Dec 18	Sep 18	Jun 18
Royalty	$4.28M	$2.35M	$2.54M	$1.42M	$1.11M	$608.00K	$216.00K	$120.00K	$55.00K	-	-	-	-
License	$250.00K	$2.50M	$2.70M	$20.70M	$2.00M	$4.00M	$2.75M	-	$53.50M	$10.00M	$10.00M	$30.50M	-
Product	$48.86M	$50.02M	$48.77M	$48.61M	$58.71M	$53.48M	$53.86M	$45.57M	$61.08M	$52.63M	$50.77M	-	-

Puma Bio's latest quarterly revenue breakdown by geography, as of Jun 21: Product (91.52%), Royalty (8.01%), and License (0.47%).

Puma Bio Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
PBYI	Puma Bio	$228.37M	$54.48M
ARCT	Arcturus Therapeutics	$82.03M	$17.15M
VYGR	Voyager Therapeutics	$40.37M	$13.37M
TRDA	Entrada Therapeutics	$25.42M	$1.61M
ALLO	Allogene Therapeutics	$22.00K	-
ABEO	Abeona Therapeutics	-	-
HUMA	Humacyte	-	$753.00K
SGMT	Sagimet Biosciences	-	-
ELDN	Eledon Pharmaceuticals	-	-
AVIR	Atea Pharmaceuticals	-	-

PBYI Revenue FAQ

What is Puma Bio’s yearly revenue?

Puma Bio's yearly revenue for 2025 was $228.37M, representing a decrease of -0.91% compared to 2024. The company's yearly revenue for 2024 was $230.47M, representing a decrease of -2.19% compared to 2023. PBYI's yearly revenue for 2023 was $235.64M, representing an increase of 3.34% compared to 2022.

What is Puma Bio’s quarterly revenue?

Puma Bio's quarterly revenue for Q3 2025 was $54.48M, a 3.89% increase from the previous quarter (Q2 2025), and a -32.36% decrease year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $52.44M, a 13.97% increase from the previous quarter (Q1 2025), and a 11.37% increase year-over-year (Q2 2024). PBYI's quarterly revenue for Q1 2025 was $46.01M, a -22.12% decrease from the previous quarter (Q4 2024), and a 5.12% increase year-over-year (Q1 2024).

What is Puma Bio’s revenue growth rate?

Puma Bio's revenue growth rate for the last 3 years (2023-2025) was -3.08%, and for the last 5 years (2021-2025) was -9.79%.

What are Puma Bio’s revenue streams?

Puma Bio's revenue streams in c 25 are Royalty, and Product. Royalty generated $24.3M in revenue, accounting 10.64% of the company's total revenue, down -31.13% year-over-year. Product generated $204.07M in revenue, accounting 89.36% of the company's total revenue, up 4.55% year-over-year.

What is Puma Bio’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Puma Bio was Product. This segment made a revenue of $204.07M, representing 89.36% of the company's total revenue.